Sunday, December 4, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

WILMINGTON, Del. - MAP Pharmaceuticals is selling itself too cheaply to Allergan, for $25 a share or $958 million, shareholders claim in Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...